Ringoes, NJ, United States of America

Nareshkumar Jain

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.1

ph-index = 1


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Nareshkumar Jain: Innovator in Pharmaceutical Chemistry

Introduction

Nareshkumar Jain is a notable inventor based in Ringoes, NJ (US), recognized for his contributions to pharmaceutical chemistry. With a total of four patents to his name, Jain has made significant advancements in the field, particularly in the synthesis of complex compounds.

Latest Patents

Jain's latest patents include a method for the preparation of maytansinol, which involves a scaled process of reacting a compound of Formula I with at least one organometallic reagent to produce the compound of Formula II. This innovative approach allows for the efficient isolation of the desired compound. Another significant patent focuses on pharmaceutical compositions comprising macrolide diastereomers. This disclosure highlights the improved therapeutic profile of these diastereomers in inhibiting cell proliferation compared to traditional mixtures. Additionally, Jain's work includes the development of drug-ligand conjugates formed using these diastereomers, along with novel methods for their preparation and therapeutic applications.

Career Highlights

Throughout his career, Nareshkumar Jain has worked with prominent companies in the pharmaceutical industry, including Regeneron Pharmaceuticals, Inc. and Celgene Corporation. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Jain has collaborated with several professionals in his field, including Sanjeevani Ghone and Thomas Nittoli. These collaborations have further enhanced his research and development efforts.

Conclusion

Nareshkumar Jain's work in pharmaceutical chemistry exemplifies the impact of innovation in drug development. His patents and collaborations reflect a commitment to advancing therapeutic solutions for various medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…